Cerebral adaptations to chronic anemia in a model of erythropoietin- deficient mice exposed to hypoxia

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 296, Issue 3, 2009, Pages

  El Hasnaoui Saadani, Raja ^a   Pichon, Aurélien ^a   Marchant, Dominique ^a   Olivier, Paul ^a   Launay, Thierry ^a   Quidu, Patricia ^a   Beaudry, Michèle ^a   Duvallet, Alain ^a   Richalet, Jean Paul ^a   Favret, Fabrice ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Angiogenesis; Cerebral cortex; Chronic anemia; Erythropoietin; Hypoxia

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NEURONAL NITRIC OXIDE SYNTHASE; STAT5 PROTEIN; VASCULOTROPIN; HEMOGLOBIN; HIF1A PROTEIN, MOUSE; NITRIC OXIDE; RNA; VASCULOTROPIN A;

ANEMIA; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CAPILLARY; HYPOXIA; MOUSE; NEUROPROTECTION; NONHUMAN; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; ANIMAL; ANOXIA; BIOSYNTHESIS; BODY WEIGHT; BRAIN; BRAIN CORTEX; CBA MOUSE; CHRONIC DISEASE; GENETICS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; MALE; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANEMIA; ANIMALS; ANOXIA; BODY WEIGHT; BRAIN; CEREBRAL CORTEX; CHRONIC DISEASE; ERYTHROPOIETIN; HEMOGLOBINS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED CBA; MICE, KNOCKOUT; NITRIC OXIDE; RECEPTORS, ERYTHROPOIETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STAT5 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64149121692     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00119.2008     Document Type: Article

References (61)

1. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9: 836-844, 1996.
2. Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104: 2073-2080, 2004. (Pubitemid 39297859)
3. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19: 643-651, 1999. (Pubitemid 30161216)
4. Binley K, Askham Z, Iqball S, Spearman H, Martin L, de Alwis M, Thrasher AJ, Ali RR, Maxwell PH, Kingsman S, Naylor S. Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy. Blood 100: 2406-2413, 2002.
5. Boero JA, Ascher J, Arregui A, Rovainen C, Woosley TA. Increased brain capillaries in chronic hypoxia. J Appl Physiol 86: 1211-1219, 1999. (Pubitemid 29172154)
6. Brines M, Cerami A. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int 70: 246-250. 2006. (Pubitemid 44086573)
7. Chavez JC, Agani F, Pichiule P, LaManna JC. Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia. J Appl Physiol 89: 1937-1942, 2000.
8. Chin K, Yu X, Beleslin-Cokic B, Liu C, Shen K, Mohrenweiser HW, Noguchi CT. Production and processing of erythropoietin receptor transcripts in brain. Brain Res Mol Brain Res 81: 29-42, 2000.
9. Déry MA, Michaud MD, Richard DE. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37: 535-540, 2005.
10. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412: 641-647, 2001. (Pubitemid 32772276)
11. Dunst J, Becker A, Lautenschlager C, Markau S, Becker H, Fischer K, Haensgen G. Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF). Strahlenther Onkol 178: 436-441, 2002.
12. Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, Spahr C, Um M, Van G, Begley CG. Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 107: 1892-1895, 2006. (Corrigendum. Blood 107: 3454, 2006). (Pubitemid 43289368)
13. Grote K, Luchtefeld M, Schieffer B. JANUS under stress - role of JAK/STAT signaling pathway in vascular diseases. Vascul Pharmacol 43: 357-363, 2005. (Pubitemid 41608760)
14. Hare GM, Mazer CD, Mak W, Gorczynski RM, Hum KM, Kim SY, Wyard L, Barr A, Qu R, Baker AJ. Hemodilutional anemia is associated with increased cerebral neuronal nitric oxide synthase gene expression. J Appl Physiol 94: 2058-2067, 2003. (Pubitemid 36457460)
15. Hare GM. Anaemia and the brain. Curr Opin Anaesthesiol 17: 363-369, 2004.
16. Hudetz AG, Shen H, Kampine JP. Nitric oxide from neuronal NOS plays critical role in cerebral capillary flow response to hypoxia. Am J Physiol Heart Circ Physiol 274: H982-H989, 1998. (Pubitemid 28158295)
17. Kanaan A, Farahani R, Douglas RM, Lamanna JC, Haddad GG. Effect of chronic continuous or intermittent hypoxia and reoxygenation on cerebral capillary density and myelination. Am J Physiol Regul Integr Comp Physiol 290: R1105-R1114, 2006.
18. Kaur C, Sivakumar V, Ang LS, Sundaresan A. Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity. J Neurochem 98: 1200-1216, 2006. (Pubitemid 44127795)
19. Kertesz N, Wu J, Chen TH, Sucov HM, Wu H. The role of erythropoietin in regulating angiogenesis. Dev Biol 276:101-110, 2004. (Pubitemid 39452849)
20. Kuo NT, Benhayon D, Przybylski RJ, Martin RJ, LaManna JC. Prolonged hypoxia increases vascular endothelial growth factor mRNA and protein in adult mouse brain. J Appl Physiol 86: 260-264, 1999. (Pubitemid 29046965)
21. LaManna JC, Chavez JC, Pichiule P. Structural and functional adaptation to hypoxia in the rat brain. J Exp Biol 207: 3163-3169, 2004. (Pubitemid 39275291)
22. LaManna JC, McCracken KA, Strohl KP. Changes in regional cerebral blood flow and sucrose space after 3-4 weeks of hypobaric hypoxia (0.5 ATM). Adv Exp Med Biol 248: 471-477, 1989.
23. LaManna JC, Vendel LM, Farrell RM. Brain adaptation to chronic hypobaric hypoxia in rats. J Appl Physiol 72: 2238-2243, 1992.
24. Lauro KL, LaManna JC. Adequacy of cerebral vascular remodeling following three weeks of hypobaric hypoxia. Examined by an integrated composite analytical model. Adv Exp Med Biol 411: 369-376, 1997.
25. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp Mol Med 36: 1-12, 2004.
26. Lee MY, Joung YH, Lim EJ, Park JH, Ye SK, Park T, Zhang Z, Park DK, Lee KJ, Yang YM. Phosphorylation and activation of STAT proteins by hypoxia in breast cancer cells. Breast 15: 187-195, 2006.
27. Liu J, Narasimhan P, Yu F, Chan PH. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke 36: 1264-1269, 2005. (Pubitemid 40798749)
28. López-Ramos, JC, Martínez-Romero R, Molina F, Cañuelo A, Martínez-Lara E, Siles E, Peinado MA. Evidence of a decrease in nitric oxide-storage molecules following acute hypoxia and/or hypobaria, by means of chemiluminescence analysis. Nitric Oxide 13: 62-67, 2005. (Pubitemid 40853970)
29. Macarlupu JL, Buvry A, Morel OE, Leon-Velarde F, Richalet JP, Favret F. Time course of ventilatory acclimatisation to hypoxia in a model of anemic transgenic mice. Respir Physiol Neurobiol 53: 14-22, 2006. (Pubitemid 44107821)
30. Macarlupu JL, Buvry A, Morel OE, Leon-Velarde F, Richalet JP, Favret F. Characterisation of the ventilatory response to hypoxia in a model of transgenic anemic mice. Respir Physiol Neurobiol 150: 19-26, 2006. (Pubitemid 43156395)
31. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60, 1997. (Pubitemid 27450643)
32. Marti HH. Erythropoietin and the hypoxic brain. J Exp Biol 207: 3233-3242, 2004.
33. Marzo F, Lavorgna A, Coluzzi G, Santucci E, Tarantino F, Rio T, Conti E, Autore C, Agati L, Andreotti F. Erythropoietin in heart and vessels: focus on transcription and signalling pathways. J Thromb Thrombolysis 26: 183-187, 2008.
34. Maxwell PH, Osmond MK, Pugh CW, Heryet A, Nicholls LG, Tan CC, Doe BG, Ferguson DJ, Johnson MH, Ratcliffe PJ. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44: 1149-1162, 1993. (Pubitemid 23316488)
35. McLaren AT, Marsden PA, Mazer CD, Baker AJ, Stewart DJ, Tsui AK, Li X, Yucel Y, Robb M, Boyd SR, Liu E, Yu J, Hare GM. Increased expression of HIF-1alpha, nNOS, and VEGF in the cerebral cortex of anemic rats. Am J Physiol Regul Integr Comp Physiol 292: R403-R414, 2007. (Pubitemid 46089855)
36. McPherson RJ, Juul SE. Recent trends in erythropoietin-mediated neuroprotection. Int J Dev Neurosci 26: 103-111, 2008.
37. Moncada S, Higgs EA. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 21: 361-374, 1991.
38. Pearce WJ. Mechanisms of hypoxic cerebral vasodilatation. Pharmacol Ther 65: 75-91, 1995.
39. Pelligrino DA, Wang Q, Koenig HM, Albrecht RF. Role of nitric oxide, adenosine, N-methyl-D-aspartate receptors, and neuronal activation in hypoxia-induced pial arteriolar dilation in rats. Brain Res 704: 61-70, 1995.
40. Pichiule P, Chavez JC, LaManna JC. Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J Biol Chem 279: 12171-12180, 2004. (Pubitemid 38445782)
41. Pichiule P, Chavez JC, Przybylski RJ, LaManna JC. Increase of neuronal nitric oxide synthase during chronic hypoxia. Adv Exp Med Biol 454: 319-323, 1998. (Pubitemid 29005544)
42. Pichiule P, LaManna JC. Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxia. J Appl Physiol 93: 1131-1139, 2002.
43. Rakusan K, Cicutti N, Kolar F. Effect of anemia on cardiac function, microvascular structure, and capillary hematocrit in rat hearts. Am J Physiol Heart Circ Physiol 280: H1407-H1414, 2001. (Pubitemid 32537909)
44. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1 alpha in vascular smooth muscle cells. J Biol Chem 275: 26765-26771, 2000.
45. Schoch HJ, Fischer S, Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125: 2549-2557, 2002. (Pubitemid 35303512)
46. Semenza GL. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology 19: 176-182, 2004.
47. Serrano J, Encinas JM, Fernandez AP, Rodrigo J, Martinez A. Effects of acute hypobaric hypoxia on the nitric oxide system of the rat cerebral cortex: Protective role of nitric oxide inhibitors. Neuroscience 142: 799-808, 2006. (Pubitemid 44485925)
48. Serrano J, Encinas JM, Salas E, Fernandez AP, Castro-Blanco S, Fernandez-Vizarra P, Bentura ML, Rodrigo J. Hypobaric hypoxia modifies constitutive nitric oxide synthase activity and protein nitration in the rat cerebellum. Brain Res 976: 109-119, 2003. (Pubitemid 36588542)
49. Soliz J, Gassmann M, Joseph V. Soluble erythropoietin receptor is present in the mouse brain and is required for the ventilatory acclimatization to hypoxia. J Physiol 583: 329-336, 2007. (Pubitemid 47244262)
50. Soliz J, Joseph V, Soulage C, Becskei C, Vogel J, Pequignot JM, Ogunshola O, Gassmann M. Erythropoietin regulates hypoxic ventilation in mice by interacting with brainstem and carotid bodies. J Physiol 568: 559-571, 2005. (Pubitemid 41555458)
51. Spandou E, Papoutsopoulou S, Soubasi V, Karkavelas G, Simeonidou C, Kremenopoulos G, Guiba-Tziampiri O. Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain. Brain Res 1021: 167-172, 2004. (Pubitemid 39165793)
52. Todd MM, Farrell S, Wu B. Cerebral blood flow during hypoxemia and hemodilution in rabbits: different roles for nitric oxide? J Cereb Blood Flow Metab 17: 1319-1325, 1997. (Pubitemid 27520123)
53. Trollmann R, Schneider J, Keller S, Strasser K, Wenzel D, Rascher W, Ogunshola OO, Gassmann M. HIF-1-regulated vasoactive systems are differentially involved in acute hypoxic stress responses of the developing brain of newborn mice and are not affected by levetiracetam. Brain Res 1199: 27-36, 2008.
54. Ward ME, Toporsian M, Scott JA, Teoh H, Govindaraju V, Quan A, Wener AD, Wang G, Bevan SC, Newton DC, Marsden PA. Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant. J Clin Invest 115: 3128-3139, 2005. (Pubitemid 41567577)
55. Ward NL, Moore E, Noon K, Spassil N, Keenan E, Ivanco TL, LaManna JC. Cerebral angiogenic factors, angiogenesis, and physiological response to chronic hypoxia differ among four commonly used mouse strains. J Appl Physiol 102: 1927-1935, 2007. (Pubitemid 46701964)
56. Xu K, Lamanna JC. Chronic hypoxia and the cerebral circulation. J Appl Physiol 100: 725-730, 2006. (Pubitemid 43671631)
57. Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K, Nakano Y. Brain capillary endothelial cells express two forms of erythropoietin receptor MrnA. Eur J Biochem 239: 494-500, 1996. (Pubitemid 26246558)
58. Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY, Kuriyama T, Cheng SH, Gregory RJ, Jiang C. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93:664-673, 2003. (Pubitemid 37222163)
59. Yamasaki M, Mishima HK, Yamashita H, Kashiwagi K, Murata K, Minamoto A, Inaba T. Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res 1050: 15-26, 2005. (Pubitemid 40922713)
60. Yasuda Y, Masuda S, Chikuma M, Inoue K, Nagao M, Sasaki R. Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem 273: 25381-25387, 1998. (Pubitemid 28443305)
61. Yin JH, Yang DI, Ku G, Hsu CY. iNOS expression inhibits hypoxia-inducible factor-1 activity. Biochem Biophys Res Commun 279: 30-34, 2000.